Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Germany's justice ministry plans to present measures in the near future that would allow authorities to more effectively combat the use of artificial intelligence to manipulate images in ways that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback